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Melioidosis, caused by Burkholderia pseudomallei, is endemic in areas of Southeast Asia. Published case reports from the ThaiMyanmar border are absent and the general belief is that melioidosis does not occur in this region. Presented below are two case reports suggesting that melioidosis does in fact occur and may be under-recognized and not reported.
The first case of this series was a 17-year old female who presented with an intermittent fever for two months, more than 10% weight loss and confusion. She had been previously healthy. Her parents were farmers and the family lived on their farm, growing rice, corn and beans, in eastern Myanmar along the Thailand border. On physical examination, her temperature was 40.1°C, pulse 130 bpm, respiration 28/min, and blood pressure 80/50 mmHg. In general, she was prostrate with conjunctival pallor. Her Glasgow Coma Score was 10/15. The cardiovascular and pulmonary exams were normal aside from tachycardia and tachypnea. Abdominal examination revealed hepatosplenomegaly. There were no other significant findings on clinical exam. Evidence from a random dextrose level test (432 mg/dL) and a urine dipstick; white blood cell 1+, ketone 3+, glucose 1+; were consistent with anorexia. Repeated random dextrose levels remained elevated and the maximum result was 520 mg/dL. A malaria smear showed Plasmodium vivax at a low parasitemia. Because of decreased consciousness, a lumbar puncture was performed and clear cerebrospinal fluid (CSF) was obtained. The CSF cell counts were normal and no organisms were grown after 48 hours of culture. Blood cultures were also sent. The patient was resuscitated with normal saline, given ceftriaxone 1 g intravenous BID and stabilized. Treatment with chloroquine 500 mg oral daily was started for P. vivax malaria. Over the following two days, further laboratory results were obtained. A complete blood count (CBC) showed an elevated white blood count (WBC) at 13.5 10 3 /µL with a neutrophilia, hemoglobin (Hgb) 14.1 g/dL and a normal platelet count. Chest X-ray was abnormal with a left sided consolidation, cavitation on the right side and bilateral hilar lymphadenopathy. Sputum tested for acid fast bacilli was negative. Despite the addition of gentamicin 280 mg intravenous daily and appropriate supportive measures, the patient deteriorated and died within three days of hospitalization, more than eight weeks after the onset of symptoms. Admission blood culture flagged positive after one day of incubation and an identification of B. pseudomallei was made and communicated to the clinical staff one day after the patient's death.
The second case was a 45-year-old male who presented with fever and weakness for two days. He also complained of chills, rigors, cough and generalized body aches. He had a history of gastric ulcer and hypertension, neither of which were currently being treated. He was a rice farmer on the eastern border of Myanmar and Thailand and had continued to work until he fell ill. He was treated with ceftriaxone 1 g intravenous daily and metronidazole 500 mg oral TID by a village health worker. At this time a malaria smear was negative and other diagnostic testing was not performed. On the sixth day of illness he had still not improved and was sent to our clinic. At initial consultation, tympanic temperature was 36°C, pulse 76 bpm, respiration 20/min, and blood pressure 100/70 mmHg. He was generally weak but ambulatory with a Glasgow Coma Score of 15/15. He had icteric sclera and pale conjunctivae. The cardiovascular, pulmonary and abdominal exams were normal. On skin examination, a 3 cm lesion that appeared like a superficial abscess was noted on the right leg. Additional history revealed that this lesion had intermittently appeared and resolved over more than two years.
During his hospitalization, the patient developed congestive heart failure and pulmonary edema that improved with initial management. A random venous dextrose level was 110 mg/dL and field hematocrit 27%. A Urine dipstick result was abnormal with protein 2+ and blood 4+. Urine sediment was normal. Dengue rapid test was NS-1 negative, IgM and IgG positive (Standard Diagnostics, Inc, Kyonggi province, Korea). A scrub typhus rapid test for total antibody was positive (Standard Diagnostics, Inc). Stool test microscopy was negative and the stool sample was noted to be of black color. His CBC showed a Hgb 8.1 g/dL, WBC 26.2 10 3 /µL with a neutrophilia and normal platelets. Blood culture was negative. Biochemistry was sent to the district hospital, however, the results were not available immediately. His treatment regimen included cloxacillin 1 g intravenous QID, ceftriaxone 1 g intravenous daily, doxycycline 100 mg oral BID and furosemide 40 mg oral BID. Six days after admission the biochemistry results were returned and showed markedly abnormal renal function; blood urea nitrogen (BUN) 112.5 mg% and creatinine 15.4 mg%. He was diagnosed with chronic renal failure exacerbated by dengue and scrub typhus infections. After two weeks of hospitalization, the patient's clinical condition deteriorated and he died despite prolonged broad antibiotic coverage. A second blood culture obtained one day prior to his death flagged positive after one day of incubation, was identified as B. pseudomallei and results were communicated to the clinical staff one day after his death.
Diagnosis
B. pseudomallei isolates from both cases were obtained using the BacT/Alert ® 3D automatic blood culture system (bioMérieux, Marcy L'Etoile, France). The colonies of both isolates on blood agar after approximately 24 hours of incubation were non-haemolytic, smooth, white and domed shaped. On Gram staining, both isolates showed Gram negative rods with characteristic 'safety pin' appearances. The isolate from case one was oxidase positive and initially identified as B. pseudomallei using the API 20NE test kit (bioMé-rieux) which gave an 81.7% match (profile number 1056576). It was then confirmed to be B. pseudomallei using a highly specific B. Pseudomallei latex agglutination test. The B. Pseudomallei latex test, produced and provided by Mahidol Oxford Tropical Medicine
Amendments from Version 1
We have made changes to the manuscript to incorporate the comments of the 3 reviewers. More details were added about the social history, clinical exam and the timing of death from hospitalization for the first case. Additional evidence was added to support the diagnostics of B. pseudomallei and the timing of blood culture results for both cases. The discussion was expanded to include impact of disease recognition, antibiotic availability and blood culture results on patient outcome. Grammatical changes were made to improve the meaning of key sentences. During the process of review, an additional author came into view and her name has been added to the author list. In these cases, death occurred shortly after admission and the diagnosis of melioidosis was not considered until after bacteriologic results were available. Following the first case, a latex test is now performed on all oxidase positive Gram negative isolates which was not routine previously. If the clinical suspicion of melioidosis was higher, appropriate antibiotics could have been started earlier in the hospital course. In general, ceftazidime is available in Thailand and Myanmar, however, hospital care and treatment is difficult to access for the impoverished migrant populations. At SMRU field hospitals, ceftazidime was not routinely stocked, and as a consequence of these two cases, all sites with inpatient wards now carry ceftazidime.
Research Unit (MORU), is based on an anti-exopolysaccharide monoclonal antibody 1 . The isolate from case two was also oxidase positive and immediately identified as B. pseudomallei using the same B. Pseudomallei latex test. Both isolates were sent to MORU for confirmation, where they were found to have typical colony morphologies on Ashdown's agar (purple colour, metallic sheen, becoming dry and wrinkled after 48 hours), gave positive results to oxidase and latex agglutination test, L-arabinose negative, resistant to gentamicin and colistin. Susceptibility testing by disc diffusion was performed at Shoklo Malaria Research Unit (SMRU) for the first isolate and at MORU for the second (Table 1) . Two different colony types were found for case 2; one, which was susceptible to meropenem, and one with intermediate susceptibility to meropenem (bioMérieux Etest minimum inhibitory concentration of 8 µg/mL).
Management
Antimicrobial therapeutic options for melioidosis are limited due to the intrinsic resistance of the organism. Current guidelines recommend parenteral ceftazidime 50 mg/kg up to 2 g every 6 hours or meropenem 25 mg/kg up to 1 g every 8 hours for at least 10-14 days (longer in severe or complicated cases) followed by oral co-trimoxazole plus doxycycline (first-line) or co-amoxiclavulanate alone (second-line) for 20 weeks. In these cases, empiric ceftazidime or meropenem was not given due to the low suspicion for B. Pseudomallei sepsis. New data support the use of mono-therapy with oral trimethoprim-sulfamethoxazole for the oral phase of treatment 15 . This simplifies the treatment regimen and should have a positive impact on prescribing patterns in suspected cases.
Discussion
At the beginning of the 20 th century in Rangoon, Burma, Dr. Alfred Whitmore and his assistant Krishnaswami identified a new bacteria causing disease in humans. It was originally named Bacillus pseudomallei 2, 3 and renamed Burkholderia pseudomallei in 1992 4 . They proceeded to document over a hundred cases and the bacterium was isolated in over 5% of Rangoon's autopsies at that time 5 . The disease, now termed melioidosis, was named by Stanton and Fletcher in 1932 due to its clinical resemblance to glanders (an infectious disease of horses) 6 . It can present with an array of clinical symptoms but is most commonly characterised by pneumonia, abscess formation, and severe sepsis, and is associated with a high mortality 7 . It has become an important public health concern across Southeast Asia and northern Australia. In this region, incidence rates vary between 1.1/100000 and 412.7/100000 8 , and Lao PDR 
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Conclusion
Melioidosis has not been reported to be endemic in eastern Myanmar along the Thailand border, therefore, health providers may not consider it as a diagnosis in persons with sepsis. The detection of B. Pseudomallei in this case series highlights the need for further epidemiologic study and case diagnosis in this region.
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This is a challenging condition to diagnose and it is important to have a little more detail herereassuring readers that this really was is the most important part of this paper. The B. pseudomallei authors should have described the colonial morphology of the pathogen as has a B. pseudomallei characteristic appearance (although I would discourage them from re-culturing it simply to answer this point unless there is a safe laboratory environment to do so). It would also have been useful to record the API20NE score (both the 7 digit number and the percentage ID).What does SMRU stand for? Lastly, what confirmatory test did MORU perform?
Management:
It is a little unusual that management follows the discussion. In particular, the last 2 sentences are conclusions and they should be separated and labelled as such.
I have read this submission. I believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard.
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Approved with reservations: 17 February 2014
17 February 2014 Referee Report: F. Nosten and colleagues report two cases of fatal melioidosis in the Myanmar border and remind the international community that this disease was discovered in Myanmar. Melioidosis is probably a forgotten public health issue in Myanmar and this article has the advantage of emphasizing it. However a description of the Myanmar environment, healthcare system and available antibiotics could help to better understand the general background around these two cases.
I have a few comments on the cases:
The first case illustrates a chronic pulmonary melioidosis with a fatal septic choc due to . The second case is about a fatal disseminated melioidosis from cutaneous inoculation. What is less clear is the global clinical presentation. The patient had initial pulmonary oedema. Maybe it would be helpful to discuss pulmonary melioidosis and to have the result of the chest X-ray (if it could have been done in this setting).
" " -This statement doesn't bring out any new evidence. stool sample was noted to be of black color "A second blood culture obtained one day prior to his death grew Burkholderia pseudomallei after ." -Does that mean that you got the result after his death? How long did it one day of incubation take to get the result? 1.
2.
3.
1.
2.
3.
." -Does that mean that you got the result after his death? How long did it one day of incubation take to get the result? Do the authors think that earlier result of blood cultures could have had a positive impact on the outcome of their two patients? It could be interesting to discuss it. Do the authors have any comments on the Ashdown media, which is a cheap, specific and easy-to-make medium. Could it be implemented in the Myanmar border to help diagnosing cases?
Is ceftazidime available in Myanmar?
I have read this submission. I believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard, however I have significant reservations, as outlined above.
No competing interests were disclosed. Thank you for reviewing this case series. Our reply to your comments are as follows:
Response to comments on the first case:
Land use along the Thailand Myanmar border is primarily agricultural. Crops that are grown are wide ranging, but most importantly, rice farming is common. All rice farms have some form of irrigation. As is custom, this patient and her family lived in a wooden home situated beside the fields of the farm where they worked and would certainly have been exposed to wet soil and natural water sources on a daily basis.
"Abdominal examination revealed a 1cm liver and spleen" would mean that both the liver and spleen were enlarged and both measured 1cm.
The patient's symptoms had started approximately 8 weeks before admission. She was admitted 3 days prior to her death and the case report describes the events over those 3 days. Response to comments on the second case:
At our clinics, situated in a resource-limited setting, we are not able to test stool for occult blood, therefore we rely on the visual examination to determine if there is gastrointestinal bleeding. In this particular case, the presence of melanic stool would indicate either the severity of his sepsis or an underlying gastrointestinal disorder contributing to his poor clinical condition.
The second blood culture result grew within 24 hours. Results were called B. pseudomallei immediately to the clinical doctor, however, the patient had already expired the day prior.
Gram stain, blood culture results, and sensitivities when available are called immediately to 1.
2.
, Shoklo Malaria Research Unit, Thailand Cindy Chu Posted: 28 Jan 2014
Thank you for your useful comments. Our reply to your points are as follows:
We agree that it would have been better had diabetes been ruled out. A blood sample for glycated hemoglobin was not sent to the sub-district hospitals, and was not available at our hospital. In this case, repeated random dextrose levels remained elevated with the highest measure being 520 mg/dL. The urine dipstick results were WBC 1+, ketones 3+, glucose 1+. Serum biochemistry for K+ was 3.14 mmol/L and for Na+ was 129.5 mmol/L, not consistent with dehydration.
Oral chloroquine 500 mg daily was given for 2 days. The patient expired before the final dose could be given.
The patient's symptoms had started approximately 8 weeks before admission. She was admitted 3 days prior to her death and the case report describes the events over those 3 days.
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